Franklin Templeton, Inc. filed a Schedule 13G with the SEC on October 26, 2026, disclosing beneficial ownership of 3,807,236 shares of Jade Biosciences, Inc. common stock as of September 30, 2026, representing 6.0% of the class.

Key Highlights

  • Aggregate beneficial ownership: Franklin Templeton, Inc. reported 3,807,236 shares of Jade Biosciences common stock, equal to 6.0% of the class.
  • Sole voting power: 3,706,532 shares are attributed to Franklin Templeton, Inc. in the filing's individual reporting-person table, with sole dispositive power over 3,807,236 shares.
  • Subsidiary breakdown: Franklin Advisers, Inc. holds sole voting and dispositive power over 2,004,120 shares; Franklin Mutual Advisers, LLC holds sole voting power over 1,702,377 shares and sole dispositive power over 1,803,081 shares; Fiduciary Trust International LLC holds power over 35 shares.
  • Name change noted: The filing states that effective August 17, 2026, Franklin Resources, Inc. was renamed Franklin Templeton, Inc.
  • Event date: The date of the event requiring the filing is listed as September 30, 2026.
  • Co-filers Charles B. Johnson and Rupert H. Johnson, Jr. each report 0 shares beneficially owned and 0% of the class.

Franklin Templeton's Schedule 13G Filing on Jade Biosciences Common Stock

According to the Schedule 13G filed on October 26, 2026, Franklin Templeton, Inc., a Delaware holding company, disclosed aggregate beneficial ownership of 3,807,236 shares of Jade Biosciences, Inc. common stock (par value $0.0001 per share, CUSIP 008064206). The filing identifies the triggering event date as September 30, 2026, and classifies Franklin Templeton, Inc. as a parent holding company and corporation (HC, CO) under SEC reporting categories.

The filing breaks down voting and dispositive authority among three investment management subsidiaries. Franklin Advisers, Inc. holds sole voting and sole dispositive power over 2,004,120 shares. Franklin Mutual Advisers, LLC holds sole voting power over 1,702,377 shares and sole dispositive power over 1,803,081 shares. Fiduciary Trust International LLC holds sole voting and dispositive power over 35 shares. The filing notes that no shared voting or dispositive power exists for any reporting person.

Two individual co-filers, Charles B. Johnson and Rupert H. Johnson, Jr., both United States citizens, are also named as reporting persons classified as HC, IN. Each reports zero shares beneficially owned and 0% of the class. The filing further states that "the clients of the Investment Management Subsidiaries, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or power to direct the receipt of dividends from, and the proceeds from the sale of, the securities reported herein." The filing was signed by Thomas C. Mandia as Assistant Secretary of Franklin Templeton, Inc. and as attorney-in-fact for both individual reporting persons. Jade Biosciences, Inc. is located at 221 Crescent Street, Building 23, Suite 105, Waltham, MA 02453, according to the filing.

What Was Disclosed

Franklin Templeton, Inc. and two affiliated individuals filed a Schedule 13G reporting combined beneficial ownership of 3,807,236 shares, or 6.0%, of Jade Biosciences, Inc. common stock as of September 30, 2026, with voting and dispositive authority distributed across three investment management subsidiaries.